[Parkinson's disease: what therapeutic strategy is advisable in early stage disease?].
Clinique Neurologique, Hopital R. Salengro, CHU Lille, 59037 Lille cedex.
A
A
Destee
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents